biote Statistics
Total Valuation
biote has a market cap or net worth of $48.51 million. The enterprise value is $132.51 million.
Important Dates
The last earnings date was Wednesday, March 11, 2026, after market close.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 35.94 million shares outstanding. The number of shares has increased by 6.99% in one year.
| Current Share Class | 30.71M |
| Shares Outstanding | 35.94M |
| Shares Change (YoY) | +6.99% |
| Shares Change (QoQ) | -16.02% |
| Owned by Insiders (%) | 13.17% |
| Owned by Institutions (%) | 44.73% |
| Float | 19.84M |
Valuation Ratios
The trailing PE ratio is 1.82 and the forward PE ratio is 5.70.
| PE Ratio | 1.82 |
| Forward PE | 5.70 |
| PS Ratio | 0.24 |
| Forward PS | 0.24 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.55 |
| P/OCF Ratio | 1.33 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 3.53, with an EV/FCF ratio of 4.39.
| EV / Earnings | 4.90 |
| EV / Sales | 0.69 |
| EV / EBITDA | 3.53 |
| EV / EBIT | 3.78 |
| EV / FCF | 4.39 |
Financial Position
The company has a current ratio of 1.22
| Current Ratio | 1.22 |
| Quick Ratio | 0.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 3.64 |
| Interest Coverage | 3.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 19.06% |
| Return on Invested Capital (ROIC) | 122.09% |
| Return on Capital Employed (ROCE) | 56.00% |
| Weighted Average Cost of Capital (WACC) | 9.03% |
| Revenue Per Employee | $861,969 |
| Profits Per Employee | $121,278 |
| Employee Count | 223 |
| Asset Turnover | 1.67 |
| Inventory Turnover | 2.96 |
Taxes
In the past 12 months, biote has paid $5.99 million in taxes.
| Income Tax | 5.99M |
| Effective Tax Rate | 15.93% |
Stock Price Statistics
The stock price has decreased by -59.29% in the last 52 weeks. The beta is 1.14, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -59.29% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 2.85 |
| Relative Strength Index (RSI) | 33.83 |
| Average Volume (20 Days) | 308,250 |
Short Selling Information
The latest short interest is 1.59 million, so 4.44% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.44M |
| Short % of Shares Out | 4.44% |
| Short % of Float | 8.04% |
| Short Ratio (days to cover) | 7.91 |
Income Statement
In the last 12 months, biote had revenue of $192.22 million and earned $27.05 million in profits. Earnings per share was $0.74.
| Revenue | 192.22M |
| Gross Profit | 137.36M |
| Operating Income | 35.07M |
| Pretax Income | 37.58M |
| Net Income | 27.05M |
| EBITDA | 37.54M |
| EBIT | 35.07M |
| Earnings Per Share (EPS) | $0.74 |
Full Income StatementBalance Sheet
The company has $24.12 million in cash and $109.92 million in debt, with a net cash position of -$85.80 million or -$2.39 per share.
| Cash & Cash Equivalents | 24.12M |
| Total Debt | 109.92M |
| Net Cash | -85.80M |
| Net Cash Per Share | -$2.39 |
| Equity (Book Value) | -50.40M |
| Book Value Per Share | -1.91 |
| Working Capital | 9.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $35.19 million and capital expenditures -$5.02 million, giving a free cash flow of $30.18 million.
| Operating Cash Flow | 35.19M |
| Capital Expenditures | -5.02M |
| Depreciation & Amortization | 2.47M |
| Net Borrowing | -38.83M |
| Free Cash Flow | 30.18M |
| FCF Per Share | $0.84 |
Full Cash Flow StatementMargins
Gross margin is 71.46%, with operating and profit margins of 18.24% and 14.07%.
| Gross Margin | 71.46% |
| Operating Margin | 18.24% |
| Pretax Margin | 19.55% |
| Profit Margin | 14.07% |
| EBITDA Margin | 19.53% |
| EBIT Margin | 18.24% |
| FCF Margin | 15.70% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.99% |
| Shareholder Yield | -6.99% |
| Earnings Yield | 57.89% |
| FCF Yield | 64.60% |
Analyst Forecast
The average price target for biote is $2.25, which is 66.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.25 |
| Price Target Difference | 66.67% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.23% |
| EPS Growth Forecast (5Y) | 12.20% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.76 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 7 |
